Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Immunization
Researchers from Washington University, Department of Medicine describe findings in immunization
May 28th, 2008
Data detailed in 'The relative contribution of antibody and CD8+ T cells to vaccine immunity against West Nile encephalitis virus' have been presented. According to a study from the United States, "West Nile virus (WNV) is a mosquito borne, neurotropic flavivirus that causes a severe central nervous system (CNS) infection in humans and animals. Although commercial vaccines are available for horses, none is currently approved for human use." "In this study, we evaluated the efficacy and mechanism of immune protection of two candidate WNV vaccines in mice. A formalin-inactivated WNV vaccine induced higher levels of specific and neutralizing antibodies compared to a DNA...
Source: Vaccine Weekly (2008-05-28)
|
